× IgM nephropathy; can we still ignore it

× Nephrotic syndrome; is rituximab the light at the end of the tunnel in the treatment of adult steroid-dependent minimal change disease and focal segmental glomerulosclerosis?

× IgM nephropathy; time to act

× Histologic patterns of primary adult onset nephrotic syndrome and their clinical characteristics; a single center study from South India

× Steroid-resistant minimal change disease with ballooned podocytes

× Minimal change disease associated with balsalazide therapy for ulcerative colitis

× Potential role of Claudin-1 immunohistochemical expression and ultrastructural changes in detecting early focal segmental glomerulosclerosis